These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30789917)

  • 1. The responses of lungs and adjacent lymph nodes in responding to Yersinia pestis infection: A transcriptomic study using a non-human primate model.
    Chakraborty N; Gautam A; Muhie S; Miller SA; Moyler C; Jett M; Hammamieh R
    PLoS One; 2019; 14(2):e0209592. PubMed ID: 30789917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.
    Olson RM; Dhariwala MO; Mitchell WJ; Anderson DM
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642901
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioluminescent tracing of a Yersinia pestis pCD1
    Zhou Y; Zhou J; Ji Y; Li L; Tan Y; Tian G; Yang R; Wang X
    Microbes Infect; 2018 Mar; 20(3):166-175. PubMed ID: 29180033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.
    Comer JE; Sturdevant DE; Carmody AB; Virtaneva K; Gardner D; Long D; Rosenke R; Porcella SF; Hinnebusch BJ
    Infect Immun; 2010 Dec; 78(12):5086-98. PubMed ID: 20876291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model.
    Olson RM; Anderson DM
    PLoS One; 2019; 14(5):e0217440. PubMed ID: 31121001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence.
    Eddy JL; Schroeder JA; Zimbler DL; Caulfield AJ; Lathem WW
    J Thromb Haemost; 2016 Sep; 14(9):1833-43. PubMed ID: 27377187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Inoculation of Mice with Yersinia pestis and Processing of Pulmonary Tissue for Analysis.
    Pechous RD
    Methods Mol Biol; 2019; 2010():17-28. PubMed ID: 31177428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of Yersinia pestis during mouse pulmonary infection.
    Lawson JN; Lyons CR; Johnston SA
    DNA Cell Biol; 2006 Nov; 25(11):608-16. PubMed ID: 17132091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis.
    Hammamieh R; Muhie S; Borschel R; Gautam A; Miller SA; Chakraborty N; Jett M
    PLoS One; 2016; 11(3):e0151788. PubMed ID: 27003632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
    Dhariwala MO; Olson RM; Anderson DM
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
    [No Abstract]   [Full Text] [Related]  

  • 11. Early interaction of Yersinia pestis with APCs in the lung.
    Bosio CM; Goodyear AW; Dow SW
    J Immunol; 2005 Nov; 175(10):6750-6. PubMed ID: 16272331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.
    Lee-Lewis H; Anderson DM
    Infect Immun; 2010 Jan; 78(1):220-30. PubMed ID: 19841077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague.
    Eichelberger KR; Sepúlveda VE; Ford J; Selitsky SR; Mieczkowski PA; Parker JS; Goldman WE
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32759339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
    Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
    Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.
    Olson RM; Dhariwala MO; Mitchell WJ; Skyberg JA; Anderson DM
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of experimental plague in cats.
    Watson RP; Blanchard TW; Mense MG; Gasper PW
    Vet Pathol; 2001 Mar; 38(2):165-72. PubMed ID: 11280372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background.
    Weening EH; Cathelyn JS; Kaufman G; Lawrenz MB; Price P; Goldman WE; Miller VL
    Infect Immun; 2011 Feb; 79(2):644-52. PubMed ID: 21115720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague.
    Anderson PE; Olson RM; Willix JL; Anderson DM
    Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.